PPARα activation protects against anti-thy1 nephritis by suppressing glomerular NF-κB signaling

PPAR Research

Volumn , Issue , 2012, Pages

  Hashimoto, Koji ^a,b   Kamijo, Yuji ^a,b   Nakajima, Takero ^a   Harada, Makoto ^a,b   Higuchi, Makoto ^b   Ehara, Takashi ^b   Shigematsu, Hidekazu ^b   Aoyama, Toshifumi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CLOFIBRATE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; THY1 ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GLOMERULONEPHRITIS; IMMUNOPATHOLOGY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROLIFERATIVE GLOMERULONEPHRITIS; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION;

EID: 84862286453     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/976089     Document Type: Article

References (41)

1. Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention Circulation 2003 108 17 2154 2169 (Pubitemid 37337595)
2. Tomino Y., Immunoglobulin A nephropathy and chronic kidney disease Nephrology 2010 15 supplement 2 23 26
3. Waikhom R., Sarka D., Patil K., Non-IgA mesangioproliferative glomerulonephritis: a benignentity? Nephrology Dialysis Transplantation. In press
4. Rosselli J. L., Thacker S. M., Karpinski J. P., Petkewicz K. A., Treatment of IgA nephropathy: an update Annals of Pharmacotherapy 2011 45 10 1284 1296
5. Ashizawa M., Miyazaki M., Abe K., Furusu A., Isomoto H., Harada T., Ozono Y., Sakai H., Koji T., Kohno S., Detection of nuclear factor- b in IgA nephropathy using South Western histochemistry American Journal of Kidney Diseases 2003 42 1 76 86 (Pubitemid 36813986)
6. Aoyama T., Peters J. M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F. J., Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor (ppar ) Journal of Biological Chemistry 1998 273 10 5678 5684 (Pubitemid 28124039)
7. Kamijo Y., Hora K., Tanaka N., Usuda N., Kiyosawa K., Nakajima T., Gonzalez F. J., Aoyama T., Identification of functions of peroxisome proliferator-activated receptor in proximal tubules Journal of the American Society of Nephrology 2002 13 7 1691 1702 (Pubitemid 34700593)
8. Watanabe K., Fujii H., Takahashi T., Kodama M., Aizawa Y., Ohta Y., Ono T., Hasegawa G., Naito M., Nakajima T., Kamijo Y., Gonzalez F. J., Aoyama T., Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor associated with age-dependent cardiac toxicity Journal of Biological Chemistry 2000 275 29 22293 22299 (Pubitemid 30621813)
9. Guerre-Millo M., Gervois P., Raspé E., Madsen L., Poulain P., Derudas B., Herbert J. M., Winegar D. A., Willson T. M., Fruchart J. C., Berge R. K., Staels B., Peroxisome proliferator-activated receptor activators improve insulin sensitivity and reduce adiposity Journal of Biological Chemistry 2000 275 22 16638 16642 (Pubitemid 30398891)
10. Peters J. M., Aoyama T., Cattley R. C., Nobumitsu U., Hashimoto T., Gonzalez F. J., Role of peroxisome proliferator-activated receptor in altered cell cycle regulation in mouse liver Carcinogenesis 1998 19 11 1989 1994 (Pubitemid 28521942)
11. Tanaka N., Moriya K., Kiyosawa K., Koike K., Gonzalez F. J., Aoyama T., PPAR activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice Journal of Clinical Investigation 2008 118 2 683 694 (Pubitemid 351206557)
12. Nakajima T., Kamijo Y., Tanaka N., Sugiyama E., Tanaka E., Kiyosawa K., Fukushima Y., Peters J. M., Gonzalez F. J., Aoyama T., Peroxisome proliferator-activated receptor protects against alcohol-induced liver damage Hepatology 2004 40 4 972 980 (Pubitemid 39288131)
13. Kamijo Y., Hora K., Kono K., Takahashi K., Higuchi M., Ehara T., Kiyosawa K., Shigematsu H., Gonzalez F. J., Aoyama T., PPAR protects proximal tubular cells from acute fatty acid toxicity Journal of the American Society of Nephrology 2007 18 12 3089 3100 (Pubitemid 350223969)
14. Kono K., Kamijo Y., Hora K., Takahashi K., Higuchi M., Kiyosawa K., Shigematsu H., Gonzalez F. J., Aoyama T., PPAR attenuates the proinflammatory response in activated mesangial cells American Journal of Physiology-Renal Physiology 2009 296 2 F328 F336
15. Kamijo Y., Hora K., Nakajima T., Kono K., Takahashi K., Ito Y., Higuchi M., Kiyosawa K., Shigematsu H., Gonzalez F. J., Aoyama T., Peroxisome proliferator-activated receptor protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate Journal of the American Society of Nephrology 2007 18 1 176 188 (Pubitemid 46053431)
16. Brandt J., Pippin J., Schulze M., Hansch G. M., Alpers C. E., Johnson R. J., Gordon K., Couser W. G., Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis Kidney International 1996 49 2 335 343 (Pubitemid 26051821)
17. Wang H., Jiang X. M., Xu J. H., Xu J., Tong J. X., Wang Y. W., The profile of gene expression and role of nuclear factor B on glomerular injury in rats with Thy-1 nephritis Clinical and Experimental Immunology 2008 152 3 559 567 (Pubitemid 351661505)
18. Kosaka T., Miyajima A., Kikuchi E., Horiguchi Y., Umezawa K., Ohigashi T., Nakashima J., Asano T., Oya M., The novel NF-κB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats Nephron Experimental Nephrology 2008 110 1 e17 e24
19. Mori T., Bartocci A., Satriano J., Zuckerman A., Stanley R., Santiago A., Schlondorff D., Mouse mesangial cells produce colony-stimulating factor-1 (CSF1) and express the CSF-1 receptor Journal of Immunology 1990 144 12 4697 4702 (Pubitemid 20224105)
20. Aoyama T., Yamano S., Waxman D. J., Lapenson D. P., Meyer U. A., Fischer V., Tyndale R., Inaba T., Kalow W., Gelboin H. V., Gonzalez F. J., Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine Journal of Biological Chemistry 1989 264 18 10388 10395 (Pubitemid 19161599)
21. Aoyama T., Ueno I., Kamijo T., Hashimoto T., Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene product, is a rate-limiting enzyme in long-chain fatty acid -oxidation system. cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein Journal of Biological Chemistry 1994 269 29 19088 19094
22. Aoyama T., Uchida Y., Kelley R. I., Marble M., Hofman K., Tonsgard J. H., Rhead W. J., Hashimoto T., A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase Biochemical and Biophysical Research Communications 1993 191 3 1369 1372 (Pubitemid 23231641)
23. Delerive P., de Bosscher K., Vanden Berghe W., Fruchart J. C., Haegeman G., B. Staels, DNA binding-independent induction of I B gene transcription by PPAR Molecular Endocrinology 2002 16 5 1029 1039 (Pubitemid 34478539)
24. Delerive P., Fruchart J. C., Staels B., Peroxisome proliferator-activated receptors in inflammation control Journal of Endocrinology 2001 169 3 453 459 (Pubitemid 32536978)
25. Tanaka Y., Kume S., Araki S. I., Isshiki K., Chin-Kanasaki M., Sakaguchi M., Sugimoto T., Koya D., Haneda M., Kashiwagi A., Maegawa H., Uzu T., Fenofibrate, a PPAR agonist, has renoprotective effects in mice by enhancing renal lipolysis Kidney International 2011 79 8 871 882
26. Park H. W., Kim H. W., Ko S. H., Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor- Diabetes 2006 55 4 885 893
27. Park C. W., Zhang Y., Zhang X., Wu J., Chen L., Cha D. R., Su D., Hwang M. T., Fan X., Davis L., Striker G., Zheng F., Breyer M., Guan Y., PPAR agonist fenofibrate improves diabetic nephropathy in db/db mice Kidney International 2006 69 9 1511 1517
28. Zhao X., Li L. Y., PPAR- agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats American Journal of Nephrology 2008 28 4 598 606 (Pubitemid 351832447)
29. Saga D., Sakatsume M., Ogawa A., Tsubata Y., Kaneko Y., Kuroda T., Sato F., Ajiro J., Kondo D., Miida T., Narita I., Gejyo F., Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis Kidney International 2005 67 5 1821 1829 (Pubitemid 40577717)
30. Zhou Y., Kong X., Zhao P., Yang H., Chen L., Miao J., Zhang X., Yang J., Ding J., Guan Y., Peroxisome proliferator-activated receptor- is renoprotective in doxorubicin-induced glomerular injury Kidney International 2011 79 12 1302 1311
31. Mii A., Shimizu A., Masuda Y., Ishizaki M., Kawachi H., Iino Y., Katayama Y., Fukuda Y., Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression Laboratory Investigation 2009 89 2 164 177
32. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366 (Pubitemid 26005011)
33. Boor P., Celec P., Martin I. V., Villa L., Hodosy J., Klenovicsova K., Esposito C., Schafer S., Albrecht-Kupper B., Ostendorf T., Heidland A., Sebekova K., The peroxisome proliferator-activated receptor- agonist, BAY PP1, attenuates renal fibrosis in rats Kidney International 2011 80 11 1182 1197
34. Patel N. S. A., di Paola R., Mazzon E., Britti D., Thiemermann C., Cuzzocrea S., Peroxisome proliferator-activated receptor- contributes to the resolution of inflammation after renal ischemia/reperfusion injury Journal of Pharmacology and Experimental Therapeutics 2009 328 2 635 643
35. Li S., Bhatt R., Megyesi J., Gokden N., Shah S. V., Portilla D., PPAR- ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G American Journal of Physiology-Renal Physiology 2004 287 5 F990 F998
36. Takahashi K., Kamijo Y., Hora K., Hashimoto K., Higuchi M., Nakajima T., Ehara T., Shigematsu H., Gonzalez F. J., Aoyama T., Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPAR deterioration Toxicology and Applied Pharmacology 2011 252 3 237 249
37. Nakajima T., Tanaka N., Li G., Hu R., Kamijo Y., Hara A., Aoyama T., Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice Redox Report 2010 15 3 123 130
38. Davis T. M. E., Ting R., Best J. D., Donoghoe M. W., Drury P. L., Sullivan D. R., Jenkins A. J., O'Connell R. L., Whiting M. J., Glasziou P. P., Simes R. J., Kesaniemi Y. A., Gebski V. J., Scott R. S., Keech A. C., Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetologia 2011 54 2 280 290
39. Ansquer J. C., Foucher C., Rattier S., Taskinen M. R., Steiner G., Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the diabetes Diabetes Atherosclerosis Intervention Study (DAIS) American Journal of Kidney Diseases 2005 45 3 485 493 (Pubitemid 40341327)
40. Gonzalez F. J., Peters J. M., Cattley R. C., Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activated receptor Journal of the National Cancer Institute 1998 90 22 1702 1709 (Pubitemid 28539089)
41. Gonzalez F. J., Animal models for human risk assessment: the peroxisome proliferator-activated receptor -humanized mouse Nutrition Reviews 2007 65 6 supplement 2 S2 S6